CELLECTAR, Inc.
MADISON, WI · CIK 0001212587 · Biotech · Public
Phospholipid Drug Conjugate (PDC) platform for targeted cancer therapeutics
cellectar.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $2.7M
- 1 Form D · Feb 2010
- 200 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 11
- 7 granted · 4 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20092010
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $2,720,985 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1891 | PLEOPHARMA, INC. | — | $17M |
| 1892 | D2G ONCOLOGY, INC. | — | $6.6M |
| 1893 | OCATA THERAPEUTICS, INC. | — | — |
| 1894 | CELLECTAR, Inc. | — | $2.7M |
| 1895 | SUNNYLIFE PHARMA INC. | — | — |
| 1896 | NASH HOLDINGS, LLC | — | $1.4M |
| 1897 | Cybele Microbiome Inc | — | $1.6M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- William ClarkeDirector · Executive Officer
- Charles HarwoodDirector
- Thomas MackieDirector
- Bruce NevaiserDirector
- Neal SandyExecutive Officer
- Terry SivesindDirector
- Jamey WeichertDirector · Executive Officer
Patents
- Ether And Alkyl Phospholipid Compounds For Treating Cancer And Imaging And Detection Of Cancergranted
- Fluorescent Phospholipid Ether Compounds, Compositions, And Methods Of Usegranted
- Phospholipid Ether Analogs As Agents For Detecting And Locating Cancer, And Methods Thereofgranted
- Phospholipid Analogs As Diapeutic Agents And Methods Thereofgranted
- Ether And Alkyl Phospholipid Compounds For Treating Cancer And Imaging And Detection Of Cancergranted
- Phospholipid Analogs As Diapeutic Agents And Methods Thereofgranted
- Phospholipid Ether Analogs As Agents For Detecting And Locating Cancer, And Methods Thereofgranted
- Non-radioactive Phospholipid Compounds, Compositions, And Methods Of Useapplication
- Ether And Alkyl Phospholipid Compounds For Treating Cancer And Imaging And Detection Of Cancer Stem Cellsapplication
- Fluorescent Phospholipid Ether Compounds, Compositions, And Methods Of Useapplication
- Compositions Of Phospholipid Ether Boronic Acids And Esters And Methods For Their Synthesis And Useapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.